SkinBioTherapeutics (GB:SBTX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
SkinBioTherapeutics, a life science company, has issued 2,349,624 new ordinary shares, boosting its total to 228,435,909 shares, as it prepares for trading on the AIM Market of the London Stock Exchange. This move reflects the company’s ongoing efforts to expand its investment base and strengthen its position in the skin health sector.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
